Commissariat &#xc0; L'&#xc9;nergie Atomique Et Aux &#xc9;nergies Alternatives

Institut National De La Sante Et De La Recherche Medicale

Centre National De La Recherche Scientifique

Biomerieux, Inc.

Inserm

Patrice Marche

Thomas Courant

Herve Perron

Thierry Livache

Olivier Dellea

Fabrice Navarro Y Garcia

Isabelle Texier-Nogues

Bernard Maillere

Cyril Herrier

Hervé Perron

Yoann Roupioz

Nicolas Pasqual

Emilie Bayon

Sarah Milgram

Alexandre Rolland

Evelyne Jouvin-Marche

Loïc Leroy

Myriam Cubizolles

The present invention relates to an immunogenic composition comprising a continuous aqueous phase and a dispersed phase as droplets and comprising:

Immunogenic composition in emulsion form

The application relates to an immunogenic composition comprising a continuous aqueous phase and at least two dispersed phases 1 and 2 as droplets, wherein the dispersed phase 1 comprises a surfactant 1 bearing an antigen and the dispersed phase 2 comprises an immunostimulating agent 2, to its preparation method and its uses, notably for producing antibodies, as a drug, as a vaccine or in an immunization method.

Immunogenic composition in emulsion form comprising two dispersed phases, one comprising an antigen and the other comprising an immunostimulating agent

The present invention relates to a method for real-time measurement of the secretion of at least one compound by at least one individual cell, comprising:

Method for real-time measurement of the individual secretions of a cell

The inventive composition comprises at least one type of antibody selected in a group (i) of anti-Env-SU MSRV/HERV-W antibodies or in a group of anti-TLR4 antibodies specifically linkable with the soluble fraction of an Env protein of MSRV/HERV-W or to a TLR4 receptor of the soluble fraction of the Env protein of MSRV/HERV-W.

Composition for treating pathology associated with MSRV/HERV-W

Growing community of inventors

Meylan, France

Patrice Marche